Provided herein are novel substituted thiazoles and oxazoles of the Formula (I): ##STR00001## as well as compositions, including pharmaceutical compositions, containing the same, and the use thereof in the treatment of various neurological and psychological disorders, e.g., affective disorder, anxiety and depression, treatable by antagonizing CRF receptors.